Anti-GABA A Receptor beta 2/GABRB2 antibody [EPR10517]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications )
Rabbit Recombinant Monoclonal GABA A Receptor beta 2/GABRB2 antibody. Suitable for WB and reacts with Human samples. Cited in 14 publications.
View Alternative Names
Gamma-aminobutyric acid receptor subunit beta-2, GABA(A) receptor subunit beta-2, GABAAR subunit beta-2, GABRB2
- WB
Unknown
Western blot - Anti-GABA A Receptor beta 2/GABRB2 antibody [EPR10517] (AB156000)
All lanes:
Western blot - Anti-GABA A Receptor beta 2/GABRB2 antibody [EPR10517] (ab156000) at 1/10000 dilution
Lane 1:
HepG2 cell lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
Fetal brain lysate at 10 µg
Lane 4:
Human cerebellum lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 59 kDa
false
Related conjugates and formulations (1)
-
Anti-GABA A Receptor beta 2/GABRB2 antibody [EPR10517] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Acta pharmaceutica Sinica. B 15:4872-4885 PubMed41049747
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 164:786-812 PubMed36695027
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 21:e13573 PubMed35199454
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular neurodegeneration 16:14 PubMed33663578
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed33291462
2020
Applications
Unspecified application
Species
Unspecified reactive species
Anesthesia and analgesia 129:192-203 PubMed31082969
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:2333-2350 PubMed31063987
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pain 14:1744806918783478 PubMed29956582
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuropathology and experimental neurology 77:608-627 PubMed29788265
2018
Applications
Unspecified application
Species
Unspecified reactive species
eLife 6: PubMed28054918
2017
Applications
WB
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com